Exclusive: Joni Ernst discusses pharmaceutical prices rising

>> WHAT GOOD IS IT IN DEVELOPING
A DRUG IF THE AMERICAN A FAMILY
 
 
 
 
— FAMILY CAN’T AFFORD IT? MAX: SENATOR JONI ERNST SAYS SHE
WANTS TO SEE MAJOR CHANGES —
AROUND BIG PHARMA. IN A KCCI EXCLUSIVE INTERVIEW,
SHE CALLED THE SKYROCKETING
COSTS OF PRESCRIPTION DRUGS
“UNACCEPTABLE” AND SAYS SHE’S
WORKING TO FIX IT. SEN. ERNST: THESE PHARMACEUTICAL
COMPANIES — THERE IS LESS
COMPETITION IN THE MARKET AND
LESS INCENTIVE FOR OTHER
COMPANIES TO DEVELOP THOSE
DRUGS. THIS WOULD BE AN IMPORTANT STEP
FORWARD. MAX: WE ASKED ERNST — WHY
 
 
 
 
LAWMAKERS DON’T SIMPLY PUT
PRICE-CAPS IN PLACE, TO PREVENT
COSTS FROM GETTING SO HIGH. SHE TOLD US SHE FEARS CAPS WOULD
LIMIT THE RESEARCH AND
DEVELOPMENT — OF LIFE-SAVING
DRUGS. >> THERE ARE WAYS WE CAN DO THIS
 
 
 
 
WITHOUT NECESSARILY PUTTING
THOSE PRICE CAPS OUT THERE. IT IS

Leave a Reply

(*) Required, Your email will not be published